IMRN
Price
$1.90
Change
+$0.15 (+8.57%)
Updated
Apr 3, 01:30 PM (EDT)
Capitalization
9.15M
55 days until earnings call
LABFF
Price
$90.61
Change
+$4.56 (+5.30%)
Updated
Jul 1 closing price
Capitalization
2.79B
Ad is loading...

IMRN vs LABFF

Header iconIMRN vs LABFF Comparison
Open Charts IMRN vs LABFFBanner chart's image
Immuron
Price$1.90
Change+$0.15 (+8.57%)
Volume$382
Capitalization9.15M
LABORATORIOS FARMACEUTICOS ROVI SA
Price$90.61
Change+$4.56 (+5.30%)
Volume$100
Capitalization2.79B
IMRN vs LABFF Comparison Chart
Loading...
IMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMRN vs. LABFF commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMRN is a Hold and LABFF is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 03, 2025
Stock price -- (IMRN: $1.75 vs. LABFF: $90.61)
Brand notoriety: IMRN and LABFF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMRN: 74% vs. LABFF: 100%
Market capitalization -- IMRN: $9.15M vs. LABFF: $2.79B
IMRN [@Biotechnology] is valued at $9.15M. LABFF’s [@Biotechnology] market capitalization is $2.79B. The market cap for tickers in the [@Biotechnology] industry ranges from $308.32B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMRN’s FA Score shows that 1 FA rating(s) are green whileLABFF’s FA Score has 2 green FA rating(s).

  • IMRN’s FA Score: 1 green, 4 red.
  • LABFF’s FA Score: 2 green, 3 red.
According to our system of comparison, LABFF is a better buy in the long-term than IMRN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMRN’s TA Score shows that 2 TA indicator(s) are bullish.

  • IMRN’s TA Score: 2 bullish, 2 bearish.

Price Growth

IMRN (@Biotechnology) experienced а -2.78% price change this week, while LABFF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.00%. For the same industry, the average monthly price growth was -10.08%, and the average quarterly price growth was -14.20%.

Reported Earning Dates

IMRN is expected to report earnings on May 28, 2025.

Industries' Descriptions

@Biotechnology (-8.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LABFF($2.79B) has a higher market cap than IMRN($9.15M). IMRN YTD gains are higher at: 2.941 vs. LABFF (0.000). LABFF has higher annual earnings (EBITDA): 208M vs. IMRN (-7.35M). LABFF has more cash in the bank: 27.4M vs. IMRN (7.74M). LABFF has higher revenues than IMRN: LABFF (764M) vs IMRN (6.54M).
IMRNLABFFIMRN / LABFF
Capitalization9.15M2.79B0%
EBITDA-7.35M208M-4%
Gain YTD2.9410.000-
P/E RatioN/A28.85-
Revenue6.54M764M1%
Total Cash7.74M27.4M28%
Total DebtN/A114M-
FUNDAMENTALS RATINGS
IMRN: Fundamental Ratings
IMRN
OUTLOOK RATING
1..100
2
VALUATION
overvalued / fair valued / undervalued
1..100
30
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IMRN
RSI
ODDS (%)
N/A
Stochastic
ODDS (%)
Bullish Trend 29 days ago
90%
Momentum
ODDS (%)
N/A
MACD
ODDS (%)
N/A
TrendWeek
ODDS (%)
Bearish Trend 29 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 29 days ago
86%
Advances
ODDS (%)
N/A
Declines
ODDS (%)
Bearish Trend about 1 month ago
89%
BollingerBands
ODDS (%)
Bullish Trend 29 days ago
76%
Aroon
ODDS (%)
Bearish Trend 29 days ago
88%
View a ticker or compare two or three
Ad is loading...
IMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MCMVX19.190.22
+1.16%
Monongahela All Cap Value
CBBYX6.38N/A
N/A
AB Relative Value Advisor
OWSMX15.86N/A
N/A
Old Westbury Small & Mid Cap Strategies
IYPCX18.57N/A
N/A
Macquarie Systematic Em Mkts Eq R
GQHPX13.53N/A
N/A
GQG Partners US Quality Value Fund Inv

LABFF and

Correlation & Price change

A.I.dvisor indicates that over the last year, LABFF has been closely correlated with IMRN. These tickers have moved in lockstep 81% of the time. This A.I.-generated data suggests there is a high statistical probability that if LABFF jumps, then IMRN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LABFF
1D Price
Change %
LABFF100%
N/A
IMRN - LABFF
81%
Closely correlated
N/A
MNMD - LABFF
47%
Loosely correlated
+7.76%
CELZ - LABFF
35%
Loosely correlated
+7.00%
NVO - LABFF
29%
Poorly correlated
+0.31%
QSI - LABFF
26%
Poorly correlated
+2.50%
More